Chair: Good Morning. Yesterday we had a fruitful discussion on the issues of the consequences and risk associated with non medical use of drugs. Today we will be discussing the low availability of nationally controlled substances for medical and scientific purposes, including for the relief of pain and palliative care. Before we start a discussion, …
Side Event / Launch of the Shadow Report for the Midterm Review of the 2019 Ministerial Declaration on Drugs
Ann Fordham, IDPC: Good afternoon and welcome to this significant event, titled “Are we on track?” where the International Drug Policy Consortium (IDPC) will be presenting our shadow report for the midterm review of the 2019 Ministerial Declaration on Drugs. We are honored to have the author of the report and several esteemed speakers who …
Thematic Session / Sessions 9 & 10 – New psychoactive substances / synthetic opioids and the non-medical use of prescription drugs
Civil society submissions Amy Ronshausen, Drug Free America Foundation [Video] [Statement] Valentina Mankiyeva, VNGOC (Kazakhstan Forum for People Who Use Drugs) [Video] [Statement] Bilgesu Özcan, Turkish Green Crescent [Video] [Statement] Monica Richards, VNGOC (Benzo Research Project, United Kingdom) [Video] [Statement] Olawale Olaleye, VNGOC (Brandeis University Opioid Policy Research Collaborative, Nigeria) [Video] [Statement] Cheung Lik Hang, …
CND Thematic Discussions // Session 8 – High transmission of HIV, HCV and other blood-borne diseases associated with drug use
Presenter 1, UNODC: Thank you, Mr. Chair, excellencies, ladies, and gentlemen. I will briefly discuss the lessons learned in the actual UNODC Partnership Project addressing drug use issues in Afghanistan amid the continuing humanitarian crisis. The project received funding support from the European Union for the implementation period 2023 to 2026. Addressing existing fragilities, including …
CND Thematic Discussions / Session 7 – Increase in drug-related deaths – unmet need for drug treatment and health services
Chair: Good morning, everyone. Welcome to the second part of the 2023 Thematic Discussion of the Commission on Narcotic Drugs on the implementation of all international drug policy commitments following the 2019 ministerial declaration (…) Agenda is adopted. Thank you very much. Secretariat: (organizational announcements) Director of the Division of Policy Analysis and Public Affairs …
CND Thematic Discussions // Session 6 – Non-compliance of responses with international drug control conventions & human rights obligations
Chair: Welcome back. The challenge that we will be focusing on this afternoon responses not in conformity with the three international drug conventions, and not in conformity with applicable international human rights obligations pose a challenge to the implementation of joint commitment based on the principle of responsibility. UNODC Scientific Services Branch: I have a brief moment …